Journal for ImmunoTherapy of Cancer (Mar 2024)
P01.09 CRD3874-SI: a novel allosteric STING agonist with high systemic tolerability
- S Basu,
- R Ghosh,
- C Kelly,
- D Yadav,
- G Martin,
- M Banerjee,
- R Shrivastava,
- A Gautam,
- SK Middya,
- A Middya,
- N Mane,
- N Rawat,
- T Soram,
- D Chakraborty,
- R Mansuri,
- K Puniya,
- D Pryde,
- F Sônego,
- K Thiam,
- A Surya
Affiliations
- S Basu
- Queen’s Medical Centre, Nottingham, UK
- R Ghosh
- 2Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA
- C Kelly
- 1Diagnostic Radiology, Detroit Medical Center/Wayne State University, Detroit, MI, USA
- D Yadav
- Paediatrics, PGIMER, Dr. RML Hospital, N Delhi, India
- G Martin
- 3genOway, Lyon, France
- M Banerjee
- 2School of Medicine, University of Liverpool, Liverpool
- R Shrivastava
- 1Curadev Pharma, Noida, India
- A Gautam
- 2Radiology, UCSF, San Francisco, CA, USA
- SK Middya
- 1Curadev Pharma, Noida, India
- A Middya
- 1Curadev Pharma, Noida, India
- N Mane
- 1Curadev Pharma, Noida, India
- N Rawat
- 1Curadev Pharma, Noida, India
- T Soram
- 1Curadev Pharma, Noida, India
- D Chakraborty
- 1Curadev Pharma, Noida, India
- R Mansuri
- 1Curadev Pharma, Noida, India
- K Puniya
- 1Curadev Pharma, Noida, India
- D Pryde
- 2Curadev Pharma, Sandwich, UK
- F Sônego
- 3genOway, Lyon, France
- K Thiam
- 3genOway, Lyon, France
- A Surya
- 1Curadev Pharma, Noida, India
- DOI
- https://doi.org/10.1136/jitc-2024-ITOC10.19
- Journal volume & issue
-
Vol. 12,
no. Suppl 1
Abstract
No abstracts available.
